设为首页收藏本站

中国病毒学论坛|我们一直在坚持!

 找回密码
 立即注册

QQ登录

只需一步,快速开始

搜索
热搜: 活动 交友 discuz
查看: 14869|回复: 1
打印 上一主题 下一主题

[Journal Club] Programmable low-cost DNA-based platform for viral RNA detection

    [复制链接]

36

帖子

11

学分

739

金币

病毒学院小学生

Rank: 2Rank: 2

积分
11
跳转到指定楼层
楼主
发表于 2020-8-26 08:33:55 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式
https://advances.sciencemag.org/content/early/2020/08/20/sciadv.abc6246

Abstract
Detection of viruses is critical for controlling disease spread. Recent emerging viral threats including Zika virus, Ebola virus, and SARS-Cov-2 (responsible for COVID-19) highlight the cost and difficulty in responding rapidly. To address these challenges, we develop a platform for low-cost and rapid detection of viral RNA with DNA nanoswitches that mechanically reconfigure in response to specific viruses. Using Zika virus as a model system, we show non-enzymatic detection of viral RNA, with selective and multiplexed detection between related viruses and viral strains. For clinical-level sensitivity in biological fluids, we paired the assay with sample preparation using either RNA extraction or isothermal pre-amplification. Our assay requires minimal lab infrastructure, and is adaptable to other viruses, as demonstrated by quickly developing DNA nanoswitches to detect SARS-CoV-2 RNA in saliva. We expect further development and field implementation will improve our ability to detect emergent viral threats and ultimately limit their impact.

分享到:  QQ好友和群QQ好友和群 QQ空间QQ空间 腾讯微博腾讯微博 腾讯朋友腾讯朋友
收藏收藏 分享分享 支持支持34 反对反对

36

帖子

11

学分

739

金币

病毒学院小学生

Rank: 2Rank: 2

积分
11
沙发
 楼主| 发表于 2020-8-26 08:37:07 | 只看该作者
Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers

https://advances.sciencemag.org/ ... 8/20/sciadv.abc5961

Abstract
Recent reports suggest that 10-30% of SARS-CoV-2 infected patients are asymptomatic and that significant viral shedding may occur prior to symptom onset. Therefore, there is an urgent need to increase diagnostic testing capabilities to prevent disease spread. We developed P-BEST - a method for Pooling-Based Efficient SARS-CoV-2 Testing which identifies all positive subjects within a large set of samples using a single round of testing. Each sample is assigned into multiple pools using a combinatorial pooling strategy based on compressed sensing designed for maximizing carrier detection. In our current study we pooled sets of 384 samples into 48 pools providing both an 8-fold increase in testing efficiency, as well as an 8-fold reduction in test costs. We successfully identified up to 5 positive carriers within sets of 384 samples. We then used P-BEST to screen 1115 healthcare workers using 144 tests. P-BEST provides an efficient and easy-to-implement solution for increasing testing capacity that can be easily integrated into diagnostic laboratories.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

QQ|论坛App下载|Archiver|小黑屋|中国病毒学论坛    

GMT+8, 2024-11-1 08:37 , Processed in 0.200112 second(s), 28 queries .

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表